Global Multiplex Biomarker Imaging Market (2019-2027)

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

The multiplex biomarker imaging market will grow because of its ability to detect the presence of, severity, and exact location of chronic diseases and tumors, along with other applications. According to Netscribes, the global multiplex biomarker imaging market is projected to expand at a compound annual growth rate (CAGR) of 12.0% during the 2018-2023 period, generating a revenue of USD 523.59 Mn by 2023.

The global multiplex biomarker imaging market can be segmented based on:

o Techniques - immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), immunofluorescence (IF), tissue microarray (TMA), and toponome imaging system (TIS)
o Components - instruments, reagents and kits, and software
o Applications - oncology studies, drug safety, genetic characterization, and others (neurodegeneration and protein research)
o End users - research institutes, translational labs, and pharma and biopharma companies

Technique segment insights:

IHC held the largest market share (around 47%) in this segment in 2017. It is widely used in research laboratories and clinical diagnostics, owing to the advantages it offers, vis-à-vis traditional methods of enzyme staining, including specific antigen-antibody reactions. Higher incidence of chronic diseases, especially cancer, is fuelling the need for targeted treatments, thereby contributing to the growth of TMA. The market for TMA is projected to expand at a CAGR of 14.3% during the 2018-2023 period.
Component segment insights:

The instruments section held the largest market share (67%) in 2017, followed by reagents and kits. However, software is predicted to record the fastest expansion (CAGR of 15.0%) during the forecast period (2018-2023), with more automated software packages being made available to researchers. These software modules assist in the research of various diseases and improve the workflow of quantitative analysis.

Application segment insights:

Multiplex biomarker imaging products are used mostly in oncology studies. This will be followed by drug safety applications, which is expected to expand at a CAGR of 14.1% during 2018-2023.

End user segment insights:

Currently, multiplex biomarker imaging products can only be used for research purposes. Pharma and biopharma companies dominated the market's end user segment in 2017 with a share of 39%. Meanwhile, translational laboratories are projected to grow at a significant rate during the forecast period.

Regional insights:

The global multiplex biomarker imaging market can be segmented based on regions into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America dominated the global multiplex biomarker imaging market with a share of 50% in 2017, followed by Europe with a 28% share. Asia-Pacific is expected to expand at the highest CAGR (16.0%) during 2018-2023. Across North America and Europe, companies that have software and service agreements for several years are directly selling imaging products to biopharmaceutical companies, laboratories, and academic institutions.

Companies covered:

o Thermo Fisher Scientific, Inc.
o Perkin Elmer, Inc.
o Abcam Plc.
o Bio-Rad Laboratories Inc.
o US Biomax, Inc.
o Merck KGaA
o Ventana Medical Systems, Inc.
o MicroConstants, Inc.
o Leica Biosystems Nussloch GmbH
o ToposNomos Ltd.
o Illumina, Inc.

Customizations available
With the given market data, Netscribes offers customizations according to specific needs. Write to us at [email protected], or connect with us here.

Chapter 1. Executive summary

1.1. Market scope and segmentation
1.2. Key questions answered
1.3. Executive summary

Chapter 2: Global multiplex biomarker imaging market - overview

2.1. Global market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), geography-wise market revenue (USD Mn), and market attractiveness analysis
2.2. Global market drivers
2.3. Global market challenges
2.4. Global market trends
2.5. Value chain analysis
2.6. Porter's five forces analysis
2.7. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
2.8. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
2.9. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
2.10. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 3: North America multiplex biomarker imaging market

3.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
3.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
3.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
3.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
3.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 4: Europe multiplex biomarker imaging market

4.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
4.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
4.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
4.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
4.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 5: Asia-Pacific multiplex biomarker imaging market

5.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
5.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
5.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
5.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
5.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 6: Latin America multiplex biomarker imaging market

6.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
6.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
6.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
6.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
6.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 7: The Middle East and Africa multiplex biomarker imaging market

7.1. Regional market overview - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
7.2. Market segmentation based on technique (immunohistochemistry [IHC], fluorescent in the situ hybridization [FISH], immunofluorescence [IF], tissue microarray [TMA], toponome imaging system [TIS]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key market observations
7.3. Market segmentation based on component (instrument, reagents and kits, software) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
7.4. Market segmentation based on application (oncology studies, drug safety, genetic characterization and others [neurodegeneration, protein research]) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations
7.5. Market segmentation based on end user (research institutes, translational labs, pharma and biopharma companies) - historical (2015-2017) and forecasted (2018-2023) market size (USD Mn), and key observations

Chapter 8: Competitive landscape

8.1. Thermo Fisher Scientific, Inc.
8.1.a. Company snapshot
8.1.b. Product offerings
8.1.c. Growth strategies
8.1.d. Initiatives
8.1.e. Geographical presence
8.1.f. Key numbers
8.2. Perkin Elmer, Inc.
8.2.a. Company snapshot
8.2.b. Product offerings
8.2.c. Growth strategies
8.2.d. Initiatives
8.2.e. Geographical presence
8.2.f. Key numbers
8.3. Abcam Plc.
8.3.a. Company snapshot
8.3.b. Product offerings
8.3.c. Growth strategies
8.3.d. Initiatives
8.3.e. Geographical presence
8.3.f. Key numbers
8.4. Bio-Rad Laboratories Inc.
8.4.a. Company snapshot
8.4.b. Product offerings
8.4.c. Growth strategies
8.4.d. Initiatives
8.4.e. Geographical presence
8.4.f. Key numbers
8.5. U.S. Biomax, Inc.
8.5.a. Company snapshot
8.5.b. Product offerings
8.5.c. Growth strategies
8.5.d. Initiatives
8.5.e. Geographical presence
8.5.f. Key numbers
8.6. Merck KGaA
8.6.a. Company snapshot
8.6.b. Product offerings
8.6.c. Growth strategies
8.6.d. Initiatives
8.6.e. Geographical presence
8.6.f. Key numbers
8.7. Ventana Medical Systems, Inc.
8.7.a. Company snapshot
8.7.b. Product offerings
8.7.c. Growth strategies
8.7.d. Initiatives
8.7.e. Geographical presence
8.7.f. Key numbers
8.8. MicroConstants, Inc.
8.8.a. Company snapshot
8.8.b. Product offerings
8.8.c. Growth strategies
8.8.d. Initiatives
8.8.e. Geographical presence
8.8.f. Key numbers
8.9. Leica Biosystems Nussloch GmbH
8.9.a. Company snapshot
8.9.b. Product offerings
8.9.c. Growth strategies
8.9.d. Initiatives
8.9.e. Geographical presence
8.9.f. Key numbers
8.10. ToposNomos Ltd.
8.10.a. Company snapshot
8.10.b. Product offerings
8.10.c. Growth strategies
8.10.d. Initiatives
8.10.e. Geographical presence
8.10.f. Key numbers
8.11. Illumina, Inc.
8.11.a. Company snapshot
8.11.b. Product offerings
8.11.c. Growth strategies
8.11.d. Initiatives
8.11.e. Geographical presence
8.11.f. Key numbers

Chapter 9: Conclusion
9.1. Future Outlook

Appendix
o List of tables
o Research methodology
o Assumptions
o About Netscribes, Inc.

Healthcare and Pharmaceuticals

Global Cardiac Biomarker Market Research Report 2020 (Covid-19 Version)

  Price : US$ 3,500   Date : Aug 2020
  Category : Healthcare and Pharmaceuticals   Pages : 162
Medical Devices

2015-2025 Global Vascular Imaging Market Research by Type, End-Use and Region

  Price : US$ 2,900   Date : Jul 2020
  Category : Medical Devices   Pages : 117
Medical Devices

2015-2025 Global fNIRS Brain Imaging System Market Research by Type, End-Use and Region

  Price : US$ 2,900   Date : Jul 2020
  Category : Medical Devices   Pages : 105
Medical Devices

2015-2025 Global Orthopaedic Imaging Equipment Market Research by Type, End-Use and Region

  Price : US$ 2,900   Date : Jul 2020
  Category : Medical Devices   Pages : 104

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports 203, 2nd Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).

Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2020 Worldwide Market Reports. All rights reserved